{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:12:21Z","timestamp":1789053141534,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10620-026-10068-8","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:44:40Z","timestamp":1781948680000},"page":"5247-5261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tuberculosis in Cirrhosis: A Diagnostic and Therapeutic Challenge"],"prefix":"10.1007","volume":"71","author":[{"given":"Arpit","family":"Shastri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"10068_CR1","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.3390\/ijms24065202","volume":"24","author":"SSR Alsayed","year":"2023","unstructured":"Alsayed SSR, Gunosewoyo H. Tuberculosis: pathogenesis, current treatment regimens and new drug targets. Int J Mol Sci. 2023;24:5202. https:\/\/doi.org\/10.3390\/ijms24065202.","journal-title":"Int J Mol Sci."},{"key":"10068_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40249-024-01247-8","volume":"13","author":"H Lv","year":"2024","unstructured":"Lv H, Wang L, Zhang X, Dang C, Liu F, Zhang X et al. Further analysis of tuberculosis in eight high-burden countries based on the global burden of disease study 2021 data. Infect Dis Poverty. 2024;13:70. https:\/\/doi.org\/10.1186\/s40249-024-01247-8.","journal-title":"Infect Dis Poverty."},{"key":"10068_CR3","doi-asserted-by":"publisher","DOI":"10.15212\/ZOONOSES-2024-0061","author":"Z Chen","year":"2025","unstructured":"Chen Z, Wang T, Du J, Sun L, Wang G, Ni R et al. Decoding the WHO global tuberculosis report 2024: a critical analysis of global and chinese key data. Zoonoses. 2025. https:\/\/doi.org\/10.15212\/ZOONOSES-2024-0061.","journal-title":"Zoonoses."},{"key":"10068_CR4","doi-asserted-by":"publisher","unstructured":"Verstraeten R, Cossa M, Martinez L, Nelson K, Nguenha D, Garc\u00eda-Basteiro AL. Epidemiology: the current burden of tuberculosis and its determinants. In: Garc\u00eda-Basteiro AL, Ey\u00fcboglu F\u00d6, Rangaka MX, editors. The Challenge of Tuberculosis in the 21st Century [Internet]. 1st ed. European Respiratory Society; 2023 [cited 2025 Oct 15]. Available from: http:\/\/publications.ersnet.org\/lookup\/doi\/https:\/\/doi.org\/10.1183\/2312508X.10023922","DOI":"10.1183\/2312508X.10023922"},{"key":"10068_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/aje\/kwu095","volume":"180","author":"YT Lin","year":"2014","unstructured":"Lin YT, Wu PH, Lin CY, Lin MY, Chuang HY, Huang JF et al. Cirrhosis as a risk factor for tuberculosis infection\u2014a nationwide longitudinal study in Taiwan. Am J Epidemiol. 2014;180:103\u2013110. https:\/\/doi.org\/10.1093\/aje\/kwu095.","journal-title":"Am J Epidemiol."},{"key":"10068_CR6","unstructured":"Bhargava J. Prevalence of Liver Cirrhosis with Tuberculosis and its Outcome [Internet]. 2017. Available from: https:\/\/www.ijss-sn.com\/uploads\/2\/0\/1\/5\/20153321\/ijss_mar_oa19_-_2017.pdf"},{"key":"10068_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1258\/td.2010.090463","volume":"40","author":"R Baijal","year":"2010","unstructured":"Baijal R, Praveenkumar HR, Amarapurkar DN, Nagaraj K, Jain M. Prevalence of tuberculosis in patients with cirrhosis of liver in western India. Trop Doct. 2010;40:163\u2013164. https:\/\/doi.org\/10.1258\/td.2010.090463.","journal-title":"Trop Doct."},{"key":"10068_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3126\/jnhrc.v15i3.18852","volume":"15","author":"D Sharma","year":"2018","unstructured":"Sharma D, Kc S, Jaisi B. Prevalence of tuberculosis in patients with liver cirrhosis. J Nepal Health Res Counc. 2018;15:264\u2013267. https:\/\/doi.org\/10.3126\/jnhrc.v15i3.18852.","journal-title":"J Nepal Health Res Counc."},{"key":"10068_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jceh.2012.07.007","volume":"2","author":"RK Dhiman","year":"2012","unstructured":"Dhiman RK, Saraswat VA, Rajekar H, Reddy C, Chawla YK. A guide to the management of tuberculosis in patients with chronic liver disease. J Clin Exp Hepatol. 2012;2:260\u2013270. https:\/\/doi.org\/10.1016\/j.jceh.2012.07.007.","journal-title":"J Clin Exp Hepatol."},{"key":"10068_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jceh.2015.01.003","volume":"5","author":"P Sharma","year":"2015","unstructured":"Sharma P, Tyagi P, Singla V, Bansal N, Kumar A, Arora A. Clinical and biochemical profile of tuberculosis in patients with liver cirrhosis. J Clin Exp Hepatol. 2015;5:8\u201313. https:\/\/doi.org\/10.1016\/j.jceh.2015.01.003.","journal-title":"J Clin Exp Hepatol."},{"key":"10068_CR11","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/hep.22474","volume":"48","author":"DL Shawcross","year":"2008","unstructured":"Shawcross DL, Wright GAK, Stadlbauer V, Hodges SJ, Davies NA, Wheeler-Jones C et al. Ammonia impairs neutrophil phagocytic function in liver disease. Hepatol Baltim Md. 2008;48:1202\u20131212. https:\/\/doi.org\/10.1002\/hep.22474.","journal-title":"Hepatol Baltim Md."},{"key":"10068_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","volume":"9","author":"AR Bonnel","year":"2011","unstructured":"Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2011;9:727\u2013738. https:\/\/doi.org\/10.1016\/j.cgh.2011.02.031.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc."},{"key":"10068_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1440-1843.2007.01069.x","volume":"12","author":"YJ Cho","year":"2007","unstructured":"Cho YJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS et al. Clinical characteristics of tuberculosis in patients with liver cirrhosis. Respirol Carlton Vic. 2007;12:41\u2013405. https:\/\/doi.org\/10.1111\/j.1440-1843.2007.01069.x.","journal-title":"Respirol Carlton Vic."},{"key":"10068_CR14","doi-asserted-by":"publisher","first-page":"e53533","DOI":"10.7759\/cureus.53533","volume":"16","author":"PM Diggikar","year":"2024","unstructured":"Diggikar PM, Reddy HR, Mundada M, Pancholi T, Faruqi AA. Tuberculosis in a liver cirrhosis patient: a management conundrum. Cureus. 2024;16:e53533. https:\/\/doi.org\/10.7759\/cureus.53533.","journal-title":"Cureus."},{"key":"10068_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0025-2016","author":"GS McMullan","year":"2017","unstructured":"McMullan GS, Lewis JH. Tuberculosis of the liver, biliary tract, and pancreas. Microbiol Spectr. 2017. https:\/\/doi.org\/10.1128\/microbiolspec.TNMI7-0025-2016.","journal-title":"Microbiol Spectr."},{"key":"10068_CR16","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.3748\/wjg.v20.i19.5760","volume":"20","author":"N Kumar","year":"2014","unstructured":"Kumar N. Antitubercular therapy in patients with cirrhosis: challenges and options. World J Gastroenterol. 2014;20:5760. https:\/\/doi.org\/10.3748\/wjg.v20.i19.5760.","journal-title":"World J Gastroenterol."},{"key":"10068_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.18683\/germs.2020.1188","volume":"10","author":"D Arora","year":"2020","unstructured":"Arora D, Dhanashree B. Utility of smear microscopy and GeneXpert for the detection of mycobacterium tuberculosis in clinical samples. Germs. 2020;10:81\u201387. https:\/\/doi.org\/10.18683\/germs.2020.1188.","journal-title":"Germs."},{"key":"10068_CR18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s12879-024-09566-9","volume":"24","author":"KK Asare","year":"2024","unstructured":"Asare KK, Azumah DE, Adu-Gyamfi CO, Opoku YK, Adela EM, Afful P et al. Comparison of microscopic and xpert MTB diagnoses of presumptive mycobacteria tuberculosis infection: retrospective analysis of routine diagnosis at cape coast teaching hospital. BMC Infect Dis. 2024;24:660. https:\/\/doi.org\/10.1186\/s12879-024-09566-9.","journal-title":"BMC Infect Dis."},{"key":"10068_CR19","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1097\/00007890-200211270-00006","volume":"74","author":"N Benito","year":"2002","unstructured":"Benito N, Sued O, Moreno A, Horcajada JP, Gonz\u00e1lez J, Navasa M et al. Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area. Transplantation. 2002;74:1381\u20131386. https:\/\/doi.org\/10.1097\/00007890-200211270-00006.","journal-title":"Transplantation."},{"key":"10068_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0973-6883(11)60120-5","volume":"1","author":"S Rajagopala","year":"2011","unstructured":"Rajagopala S, Olithselvan A, Varghese J, Shanmugam N, Rela M. Latent mycobacterium tuberculosis infection in liver transplant recipients-controversies in current diagnosis and management. J Clin Exp Hepatol. 2011;1:34\u201337. https:\/\/doi.org\/10.1016\/S0973-6883(11)60120-5.","journal-title":"J Clin Exp Hepatol."},{"key":"10068_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3947\/ic.2023.0014","volume":"55","author":"M Mahajan","year":"2023","unstructured":"Mahajan M, Prasad ML, Kumar P, Kumar A, Chatterjee N, Singh S et al. An updated systematic review and meta-analysis for the diagnostic test accuracy of ascitic fluid adenosine deaminase in tuberculous peritonitis. Infect Chemother. 2023;55:264\u2013277. https:\/\/doi.org\/10.3947\/ic.2023.0014.","journal-title":"Infect Chemother."},{"key":"10068_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.14218\/JCTH.2013.00010","volume":"2","author":"LL Huang","year":"2014","unstructured":"Huang LL, Xia HHX, Zhu SL. Ascitic fluid analysis in the differential diagnosis of ascites: focus on cirrhotic ascites. J Clin Transl Hepatol. 2014;2:58\u201364. https:\/\/doi.org\/10.14218\/JCTH.2013.00010.","journal-title":"J Clin Transl Hepatol."},{"key":"10068_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jceh.2021.09.003","volume":"12","author":"S Mishra","year":"2022","unstructured":"Mishra S, Taneja S, De A, Muthu V, Verma N, Premkumar M et al. Tuberculosis in cirrhosis - a diagnostic and management conundrum. J Clin Exp Hepatol. 2022;12:278\u2013286. https:\/\/doi.org\/10.1016\/j.jceh.2021.09.003.","journal-title":"J Clin Exp Hepatol."},{"key":"10068_CR24","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.3748\/wjg.v18.i37.5260","volume":"18","author":"YJ Liao","year":"2012","unstructured":"Liao YJ, Wu CY, Lee SW, Lee CL, Yang SS, Chang CS et al. Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis. World J Gastroenterol. 2012;18:5260\u20135265. https:\/\/doi.org\/10.3748\/wjg.v18.i37.5260.","journal-title":"World J Gastroenterol."},{"key":"10068_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/00004836-200609000-00009","volume":"40","author":"A Riquelme","year":"2006","unstructured":"Riquelme A, Calvo M, Salech F, Valderrama S, Pattillo A, Arellano M et al. Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis. J Clin Gastroenterol. 2006;40:705\u2013710. https:\/\/doi.org\/10.1097\/00004836-200609000-00009.","journal-title":"J Clin Gastroenterol."},{"key":"10068_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0002-9343(97)89456-9","volume":"100","author":"AO Shakil","year":"1996","unstructured":"Shakil AO, Korula J, Kanel GC, Murray NG, Reynolds TB. Diagnostic features of tuberculous peritonitis in the absence and presence of chronic liver disease: a case control study. Am J Med. 1996;100:179\u2013185. https:\/\/doi.org\/10.1016\/s0002-9343(97)89456-9.","journal-title":"Am J Med."},{"key":"10068_CR27","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1128\/JCM.05434-11","volume":"49","author":"AN Zeka","year":"2011","unstructured":"Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB\/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol. 2011;49:4138\u20134141. https:\/\/doi.org\/10.1128\/JCM.05434-11.","journal-title":"J Clin Microbiol."},{"key":"10068_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0974-2727.187927","volume":"9","author":"SB Rufai","year":"2017","unstructured":"Rufai SB, Singh S, Singh A, Kumar P, Singh J, Vishal A. Performance of Xpert MTB\/RIF on ascitic fluid samples for detection of abdominal tuberculosis. J Lab Phys. 2017;9:47\u201352. https:\/\/doi.org\/10.4103\/0974-2727.187927.","journal-title":"J Lab Phys."},{"key":"10068_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/932862","author":"G Alvarez-Uria","year":"2012","unstructured":"Alvarez-Uria G, Azcona JM, Midde M, Naik PK, Reddy S, Reddy R. Rapid diagnosis of pulmonary and Extrapulmonary tuberculosis in HIV-infected patients. Comparison of LED fluorescent microscopy and the GeneXpert MTB\/RIF assay in a district hospital in India. Tuberc Res Treat. 2012. https:\/\/doi.org\/10.1155\/2012\/932862.","journal-title":"Tuberc Res Treat"},{"key":"10068_CR30","doi-asserted-by":"publisher","DOI":"10.23880\/OAJMB-16000105","author":"P Kn","year":"2016","unstructured":"Kn P. Use of GeneXpert assay for diagnosis of tuberculosis from body fluid specimens, a 2 years study. Open Access J Microbiol Biotechnol. 2016. https:\/\/doi.org\/10.23880\/OAJMB-16000105.","journal-title":"Open Access J Microbiol Biotechnol"},{"key":"10068_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.18231\/2456-9267.2019.0010","volume":"4","author":"RS Ali","year":"2019","unstructured":"Ali RS, Shilpa G, Mohamed HA, Chaitra BE, Francis R. Role of fine needle aspiration cytology as a diagnostic tool in lymphadenopathy with utility of CBNAAT in tuberculous lymphadenopathy. IP Arch Cytol Histopathol Res. 2019;4:61\u201364. https:\/\/doi.org\/10.18231\/2456-9267.2019.0010.","journal-title":"IP Arch Cytol Histopathol Res."},{"key":"10068_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40336-016-0164-0","volume":"4","author":"AO Ankrah","year":"2016","unstructured":"Ankrah AO, van der Werf TS, de Vries EFJ, Dierckx RAJO, Sathekge MM, Glaudemans AWJM. PET\/CT imaging of Mycobacterium tuberculosis infection. Clin Transl Imaging. 2016;4:131\u2013144. https:\/\/doi.org\/10.1007\/s40336-016-0164-0.","journal-title":"Clin Transl Imaging."},{"key":"10068_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3760\/cma.j.cn112147-20200821-00916","volume":"44","author":"LP Pan","year":"2021","unstructured":"Pan LP, Gao MQ, Jia HY, Huang ML, Wei RR, Sun Q et al. Diagnostic performance of a novel mycobacterium tuberculosis specific T-Cell based assay for tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi Zhonghua Jiehe He Huxi Zazhi Chin J Tuberc Respir Dis. 2021;44:443\u2013449. https:\/\/doi.org\/10.3760\/cma.j.cn112147-20200821-00916.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi Zhonghua Jiehe He Huxi Zazhi Chin J Tuberc Respir Dis."},{"key":"10068_CR34","doi-asserted-by":"publisher","first-page":"1567592","DOI":"10.3389\/fcimb.2025.1567592","volume":"15","author":"Z Yang","year":"2025","unstructured":"Yang Z, Li J, Shen J, Cao H, Wang Y, Hu S et al. Recent progress in tuberculosis diagnosis: insights into blood-based biomarkers and emerging technologies. Front Cell Infect Microbiol. 2025;15:1567592. https:\/\/doi.org\/10.3389\/fcimb.2025.1567592.","journal-title":"Front Cell Infect Microbiol."},{"key":"10068_CR35","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/hep.23534","volume":"51","author":"R Kumar","year":"2010","unstructured":"Kumar R, Shalimar BV, Khanal S, Sreenivas V, Gupta SD et al. Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome. Hepatol Baltim Md 2010;51:1665\u20131674. https:\/\/doi.org\/10.1002\/hep.23534.","journal-title":"Hepatol Baltim Md"},{"key":"10068_CR36","doi-asserted-by":"publisher","first-page":"101875","DOI":"10.5409\/wjcp.v14.i2.101875","volume":"14","author":"P Semwal","year":"2025","unstructured":"Semwal P, Saini MK, Sarma MS. Understanding antituberculosis drug-induced hepatotoxicity: risk factors and effective management strategies in the pediatric population. World J Clin Pediatr. 2025;14:101875. https:\/\/doi.org\/10.5409\/wjcp.v14.i2.101875.","journal-title":"World J Clin Pediatr."},{"key":"10068_CR37","doi-asserted-by":"publisher","first-page":"e70338","DOI":"10.1002\/jgh3.70338","volume":"10","author":"S Prasad","year":"2026","unstructured":"Prasad S, Narang H, Kedia S, Ahuja V. Anti-tubercular drug-induced liver injury: current understanding and emerging directions. JGH Open. 2026;10:e70338. https:\/\/doi.org\/10.1002\/jgh3.70338.","journal-title":"JGH Open."},{"key":"10068_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/hep.510310129","volume":"31","author":"WM Wong","year":"2000","unstructured":"Wong WM, Wu PC, Yuen MF, Cheng CC, Yew WW, Wong PC et al. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatol Baltim Md. 2000;31:201\u2013206. https:\/\/doi.org\/10.1002\/hep.510310129.","journal-title":"Hepatol Baltim Md."},{"key":"10068_CR39","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1164\/ajrccm.157.6.9711039","volume":"157","author":"JR Ungo","year":"1998","unstructured":"Ungo JR, Jones D, Ashkin D, Hollender ES, Bernstein D, Albanese AP et al. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med. 1998;157:1871\u20131876. https:\/\/doi.org\/10.1164\/ajrccm.157.6.9711039.","journal-title":"Am J Respir Crit Care Med."},{"key":"10068_CR40","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1378\/chest.06-2042","volume":"131","author":"YS Kwon","year":"2007","unstructured":"Kwon YS, Koh WJ, Suh GY, Chung MP, Kim H, Kwon OJ. Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy. Chest. 2007;131:803\u2013808. https:\/\/doi.org\/10.1378\/chest.06-2042.","journal-title":"Chest."},{"key":"10068_CR41","doi-asserted-by":"publisher","first-page":"2003300","DOI":"10.1183\/13993003.03300-2020","volume":"57","author":"F Mirzayev","year":"2021","unstructured":"Mirzayev F, Viney K, Linh NN, Gonzalez-Angulo L, Gegia M, Jaramillo E et al. World health organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update. Eur Respir J. 2021;57:2003300. https:\/\/doi.org\/10.1183\/13993003.03300-2020.","journal-title":"Eur Respir J."},{"key":"10068_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-025-01860-x","author":"J Ahmad","year":"2025","unstructured":"Ahmad J. Child-Turcotte-Pugh score-based modified anti-tubercular treatment in patients with decompensated cirrhosis with tuberculosis: a two-year retrospective observational study from North India. Indian J Gastroenterol Off J Indian Soc Gastroenterol. 2025. https:\/\/doi.org\/10.1007\/s12664-025-01860-x.","journal-title":"Indian J Gastroenterol Off J Indian Soc Gastroenterol."},{"key":"10068_CR43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.7869\/tg.2012.25","volume":"33","author":"U Sonika","year":"2012","unstructured":"Sonika U, Kar P. Tuberculosis and liver disease: management issues. Trop Gastroenterol Off J Dig Dis Found. 2012;33:102\u2013106. https:\/\/doi.org\/10.7869\/tg.2012.25.","journal-title":"Trop Gastroenterol Off J Dig Dis Found."},{"key":"10068_CR44","first-page":"13","volume":"83","author":"Y Kaneko","year":"2008","unstructured":"Kaneko Y, Nagayama N, Kawabe Y, Shimada M, Suzuki J, Kunogi M et al. Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis. Kekkaku. 2008;83:13\u201319.","journal-title":"Kekkaku."},{"key":"10068_CR45","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.it.2023.07.003","volume":"44","author":"S Bobba","year":"2023","unstructured":"Bobba S, Khader SA. Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye. Trends Immunol. 2023;44:712\u2013723. https:\/\/doi.org\/10.1016\/j.it.2023.07.003.","journal-title":"Trends Immunol."},{"key":"10068_CR46","doi-asserted-by":"publisher","first-page":"2200930","DOI":"10.1183\/13993003.00930-2022","volume":"60","author":"C Chung","year":"2022","unstructured":"Chung C, Shin JE, Jeon D, Kang H, Yim JJ, Jo KW et al. Treatment outcomes of multidrug-resistant tuberculosis with chronic kidney\/liver disease. Eur Respir J. 2022;60:2200930. https:\/\/doi.org\/10.1183\/13993003.00930-2022.","journal-title":"Eur Respir J."},{"key":"10068_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12664-024-01643-w","volume":"44","author":"R Kumar","year":"2025","unstructured":"Kumar R, Kumar A, Patel R, Prakash SS, Kumar S, Surya H et al. Incidence and risk factors of antituberculosis drug-induced liver injury in India: A systematic review and meta-analysis. Indian J Gastroenterol Off J Indian Soc Gastroenterol. 2025;44:35\u201346. https:\/\/doi.org\/10.1007\/s12664-024-01643-w.","journal-title":"Indian J Gastroenterol Off J Indian Soc Gastroenterol."},{"key":"10068_CR48","doi-asserted-by":"publisher","first-page":"e0189","DOI":"10.1097\/CLD.0000000000000189","volume":"23","author":"HC Devarbhavi","year":"2024","unstructured":"Devarbhavi HC, Philips CA. Drug-induced liver injury in patients with underlying liver disease. Clin Liver Dis. 2024;23:e0189. https:\/\/doi.org\/10.1097\/CLD.0000000000000189.","journal-title":"Clin Liver Dis."},{"key":"10068_CR49","first-page":"896","volume":"64","author":"BF Zuberi","year":"2014","unstructured":"Zuberi BF, Zuberi FF, Bader N, Alvi H, Salahuddin J. Comparison of British thoracic society and American thoracic society reintroduction guidelines for anti-tuberculous therapy induced liver injury. JPMA J Pak Med Assoc. 2014;64:896\u2013899.","journal-title":"JPMA J Pak Med Assoc."},{"key":"10068_CR50","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3389\/fimmu.2020.02006","volume":"11","author":"C Carranza","year":"2020","unstructured":"Carranza C, Pedraza-Sanchez S, de Oyarzabal-Mendez E, Torres M. Diagnosis for latent tuberculosis infection: new alternatives. Front Immunol. 2020;11:2006. https:\/\/doi.org\/10.3389\/fimmu.2020.02006.","journal-title":"Front Immunol."},{"key":"10068_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.micpath.2018.09.040","volume":"125","author":"N Rahimifard","year":"2018","unstructured":"Rahimifard N, Mahmoudi S, Mamishi S, Pourakbari B. Prevalence of latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis. Microb Pathog. 2018;125:401\u2013410. https:\/\/doi.org\/10.1016\/j.micpath.2018.09.040.","journal-title":"Microb Pathog."},{"key":"10068_CR52","unstructured":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management [Internet]. Geneva: World Health Organization; 2018 [cited 2025 Oct 15]. (WHO Guidelines Approved by the Guidelines Review Committee). Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK531235\/ PubMed PMID: 30277688."},{"key":"10068_CR53","doi-asserted-by":"publisher","first-page":"100572","DOI":"10.1016\/j.jctube.2025.100572","volume":"41","author":"L Tran","year":"2025","unstructured":"Tran L, Shah A, Kim EJ, Lopiano S, Blanchard IN, Nguyen A et al. Latent TB treatment outcomes in patients with chronic liver disease: a retrospective cohort study. J Clin Tuberc Mycobact Dis. 2025;41:100572. https:\/\/doi.org\/10.1016\/j.jctube.2025.100572.","journal-title":"J Clin Tuberc Mycobact Dis."},{"key":"10068_CR54","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/cid\/civ639","volume":"61","author":"V Tien","year":"2015","unstructured":"Tien V, Robilotti E, Callister D, Subramanian A, Lutchman G, Ho DY. Tolerability of fluoroquinolones in management of latent tuberculosis in liver transplant candidates. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;61:1631\u20131632. https:\/\/doi.org\/10.1093\/cid\/civ639.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"key":"10068_CR55","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1471-2334-9-207","volume":"15","author":"EY Kim","year":"2009","unstructured":"Kim EY, Lim JE, Jung JY, Son JY, Lee KJ, Yoon YW et al. Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis. 2009;15:207. https:\/\/doi.org\/10.1186\/1471-2334-9-207.","journal-title":"BMC Infect Dis."},{"key":"10068_CR56","doi-asserted-by":"publisher","first-page":"CD012918","DOI":"10.1002\/14651858.CD012918.pub2","volume":"12","author":"AG Grace","year":"2019","unstructured":"Grace AG, Mittal A, Jain S, Tripathy JP, Satyanarayana S, Tharyan P et al. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis. Cochrane Database Syst Rev. 2019;12:CD012918. https:\/\/doi.org\/10.1002\/14651858.CD012918.pub2.","journal-title":"Cochrane Database Syst Rev."},{"key":"10068_CR57","doi-asserted-by":"publisher","first-page":"100470","DOI":"10.1016\/j.jctube.2024.100470","volume":"37","author":"TM Johnson","year":"2024","unstructured":"Johnson TM, Rivera CG, Lee G, Zeuli JD. Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis. J Clin Tuberc Mycobact Dis. 2024;37:100470. https:\/\/doi.org\/10.1016\/j.jctube.2024.100470.","journal-title":"J Clin Tuberc Mycobact Dis."},{"key":"10068_CR58","doi-asserted-by":"publisher","first-page":"e1987","DOI":"10.1002\/mgg3.1987","volume":"10","author":"L Jaramillo-Valverde","year":"2022","unstructured":"Jaramillo-Valverde L, Levano KS, Tarazona DD, Capristano S, Zegarra-Chapo\u00f1an R, Sanchez C et al. NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients. Mol Genet Genomic Med. 2022;10:e1987. https:\/\/doi.org\/10.1002\/mgg3.1987.","journal-title":"Mol Genet Genomic Med."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10068-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10068-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10068-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:03:12Z","timestamp":1789052592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10068-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10068"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10068-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required for submission of review article.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}